<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The inaugural meeting of the International Working Group on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cytogenetics convened 22-23 October 2007 in Chicago, IL </plain></SENT>
<SENT sid="1" pm="."><plain>Under the sponsorship of the <z:hpo ids='HP_0002863'>Myelodysplastic Syndromes</z:hpo> Foundation, the group was organized to address the substantial need for worldwide standardized cytogenetic testing for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in clinical practice and research </plain></SENT>
<SENT sid="2" pm="."><plain>Eighteen cytogeneticists from 10 countries attended the first working group meeting </plain></SENT>
<SENT sid="3" pm="."><plain>Representatives from France and Austria were unable to attend the Chicago meeting </plain></SENT>
<SENT sid="4" pm="."><plain>Marilyn L </plain></SENT>
<SENT sid="5" pm="."><plain>Slovak, PhD (City of Hope, USA) served as Working Group Chair and Gordon Dewald, PhD (Mayo Clinic, USA), served as Working Group Advisor and Co-Chair </plain></SENT>
<SENT sid="6" pm="."><plain>Other members in attendance included: Mette <z:e sem="disease" ids="C0017923" disease_type="Disease or Syndrome" abbrv="">Andersen</z:e>, Rigshospitalet, Denmark; Lynda Campbell, St </plain></SENT>
<SENT sid="7" pm="."><plain>Vincent's Hospital Melbourne, Australia; Athena Cherry, Stanford University, USA; Kathy Chun, North York General Hospital, Canada; Mike Griffiths, West Midlands Regional Genetics Lab, UK; Detlef Haase, Georg-August-Universität, Germany; Claudia Haferlach, MLL Münchner Leukämielabor GmbH, Germany; Anne Hagemeijer, University of Leuven, Belgium; Barbara Hildebrandt, Institut für Humangenetik &amp; Anthropologie Dupsilonsseldorf, Germany; Douglas Horsman, BC <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Agency, Canada; M </plain></SENT>
<SENT sid="8" pm="."><plain>Anwar Iqbal, University of Rochester, USA; Suresh Jhanwar, Memorial Sloan-Kettering <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Center, USA; Bertil Johansson, University Hospital, Sweden; Michelle LeBeau, University of Chicago, USA; Kazuma Ohyashiki, Tokyo Medical University, Japan; Francesc Solé, Hospital del Mar, Spain </plain></SENT>
<SENT sid="9" pm="."><plain>The focus of the working group was to establish the natural history and clinical significance of cytogenetic anomalies associated with the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and to incorporate cytogenetic testing into the development of new treatments to cure <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Three specific goals were discussed in an effort to rapidly improve the care of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>The first goal was how to educate physicians on the appropriate use of cost effective cytogenetic testing for their patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>The second goal discussed was how best this working group could assist pharmaceutical companies with the use of appropriate cytogenetic testing in their evaluation of new drugs </plain></SENT>
<SENT sid="13" pm="."><plain>The final goal discussed was how to advance cytogenetic research into the origin, progression and clinical significance of genetic anomalies associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>